CD274 and head and neck squamous cell carcinoma: However, the marked technologic and analytic heterogeneity related to the assessment of PD-L1 expression, coupled with the novelty of this bio-selector in HNSCC, represents a diagnostic challenge for pathologists [5,6,7].